|Event Date/Time: Sep 16, 2010||End Date/Time: Sep 17, 2010|
Cancer is the fastest growing healthcare priority within the pharmaceutical industry worldwide, with rising research, treatment and commercial importance. Carefully designed and efficiently conducted clinical trial can deliver new oncology drugs and diagnostics to the marketplace. There is a number of challenges in this area which remain; specifically regarding patient recruitment and regulatory issues.
Attend to explore effective patient recruitment and enrollment strategies and understand regulatory considerations surrounding clinical trials in oncology. Leading Pharma companies will share first hand experience with adaptive trial designs and case studies on conducting clinical trials in emerging markets in CEE, APAC and India.
At this conference, you will have the chance to meet true market leaders, top speakers and real experts from the pharmaceutical industry as well as from the oncology-focused institutions and organizations. Do not miss the opportunity to gain new knowledge and join us at this event of the year.
Clinical Leader Oncology, GlaxoSmithKline, UK
Global Head of Early Clinical Development, AstraZeneca, UK
Vice President, Chief Clinical Officer, Teva, Israel
Global Clinical Operations Head Oncology, Johnson & Johnson, UK
Chief Medical Officer, Kiadis Pharma, The Netherlands
Group Head Clinical Project Management, Pfizer, Germany
Clinical Trials Consultant to MHRA, UK
Clinical Trial Head, Novartis, Switzerland
CRUK Professor of Translational Cancer Research, University of Glasgow, UK
Director Clinical Research Internal Medicine Early Stage Development, Merck Sharp & Dohme, The Netherlands
Principal Clinical Development Scientist, GlaxoSmithKline, UK
Executive Director, Oncology Global Development and Medical Affairs, Bristol Myers Squibb, France
Group Leader Global Clinical Development Unit Oncology, MerckSerono, Germany
â€¢ Recruitment and enrollment in clinical trials. Expectations and reality.
â€¢ Current regulatory situation in relation to clinical trials in the EU
â€¢ Biomarkers as valuable decision making tools in clinical drug development
â€¢ How are Pharma companies implementing and managing adaptive clinical trial
â€¢ Challenges and opportunities of conducting clinical trials in Emerging Markets
Who should attend
Vice presidents, Global heads, Heads, Directors, Senior managers, Managers within pharmaceutical companies and oncology-focused institutions and organizations responsible for:
Oncology, Clinical research and Development, Clinical trials, Clinical operations, Medical affairs, Drug development and research, Biomarkers, Imaging